Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

J&J Gives AIDS Drug Rights to Charity for Vaginal Ring

May 8 (Bloomberg) -- Johnson & Johnson gave the rights to an experimental AIDS drug to a charity that’s testing the medicine in a vaginal ring to prevent HIV infection.

J&J gave the global rights to develop and market dapivirine to the International Partnership for Microbicides, a Silver Spring, Maryland-based organization that works on developing HIV prevention tools for women, IPM said today in a statement.

The agreement expands a previous partnership in which IPM held the drug rights for developing nations. The group is testing dapivirine in a vaginal ring in two late-stage studies in Africa and may in the future combine the drug with contraceptives.

“Women are in a race against time for new HIV prevention methods and they need innovative tools to protect themselves,” Zeda Rosenberg, IPM’s chief executive officer, said in the statement.

To contact the reporter on this story: Simeon Bennett in Geneva at

To contact the editors responsible for this story: Phil Serafino at Bruce Rule, Andrew Pollack

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.